(888) 552-6760 SCHEDULE AN APPOINTMENT

Alexey Danilov,

Hematologist-Oncologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Specialties
Hematologic Oncology
Education
Medical school:
Board Certifications
  • 2012, American Board of Internal Medicine, Hematology

  • 2010, American Board of Internal Medicine, Medical Oncology

  • 2007, American Board of Internal Medicine, Internal Medicine

Degrees
  • 2000, Ph.D., Yaroslavl Medical Academy, Russia

  • 1997, M.D., summa cum laude, Yaroslavl Medical Academy, Russia

Fellowship
  • 2007-2010, Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts

Residency
  • 2004-2007, Medicine, Brown University School of Medicine, Providence, Rhode Island

Internship
  • 2004-2005, Medicine, Brown University School of Medicine, Providence, RI

Professional Experience
  • 2020-Present, Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation

  • Associate Director, Toni Stephenson Lymphoma Center, City of Hope, Duarte, CA

  • 2020-Present, Translational Medicine Chair, SWOG Lymphoma

  • 2014-2020, Assistant & Associate Professor of Medicine, Hematology - Oncology, OHSU, Portland, OR

  • 2010-2014, Assistant Professor of Medicine, Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

  • 2001-2004, Research Scholar, Tufts University School of Medicine, Boston, MA

  • 2000-2001, Instructor, Department of Medicine, Yaroslavl Medical Academy, Russia

  • 1998-1999, Instructor, Department of Pathophysiology, Yaroslavl Medical Academy, Russia

Academic Appointments
  • Marianne and Gerhard Pinkus Professor, Early Clinical Therapeutics
  • Medical Director, Early Phase Therapeutics Program for the Systems Clinical Trials Office
  • Co-Director, Toni Stephenson Lymphoma Center
  • Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation
About Me

"In oncology today, we are given great opportunities to make a lot of positive impact on the lives of our patients."

A board-certified clinician and talented researcher, Dr. Danilov is an internationally recognized physician, clinical trialist and translational investigator with expertise in chronic lymphocytic leukemia, mantle cell lymphoma and non-Hodgkin lymphoma. He is a Leukemia & Lymphoma Society Scholar and a Principal Investigator on multiple grants from the National Cancer Institute, Leukemia and Lymphoma Society, American Society of Hematology, and Lymphoma Research Foundation. He has initiated and led several dozen clinical trial protocols using novel targeted therapies and immunotherapies. Through partnerships with the National Cancer Institute and pharmaceutical industry and his leadership in the Lymphoma Committee at Southwest Oncology Group, Dr. Danilov participates in drug discovery on a global scale.

Dr. Danilov directs the City of Hope e ort in early phase clinical investigations through the National Cancer Institute Experimental Therapeutics Clinical Trials Network. As a Co-Director of the Toni Stephenson Lymphoma Center, Dr. Danilov leads clinical and translational e orts in lymphoma/leukemia at City of Hope.

An ideal fit for City of Hope, Dr. Danilov's lab concentrates on "bench to bedside" medicine, where preclinical findings lead to early phase clinical trials, ultimately translating into real treatments for real patients.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.